Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).

Cantin B, Després JP, Lamarche B, Moorjani S, Lupien PJ, Bogaty P, Bergeron J, Dagenais GR.

Am J Cardiol. 2002 Mar 15;89(6):662-6.

PMID:
11897206
2.
3.

Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.

Leroux G, Lemieux I, Lamarche B, Cantin B, Dagenais GR, Lupien PJ, Després JP.

Metabolism. 2000 Jan;49(1):53-61.

PMID:
10647064
4.

Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.

Pesant Y, Marc-Aurèle J, Bielmann P, Alaupovic P, Cartier P, Bichet D, Thibault G, Lupien PJ.

Am J Ther. 1999 May;6(3):137-47.

PMID:
10423656
5.

Apolipoprotein E polymorphism and the relationships of physical fitness to plasma lipoprotein-lipid levels in men and women.

St-Amand J, Prud'homme D, Moorjani S, Nadeau A, Tremblay A, Bouchard C, Lupien PJ, Després JP.

Med Sci Sports Exerc. 1999 May;31(5):692-7.

PMID:
10331889
6.

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.

Lamarche B, Tchernof A, Mauriège P, Cantin B, Dagenais GR, Lupien PJ, Després JP.

JAMA. 1998 Jun 24;279(24):1955-61.

PMID:
9643858
7.

Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.

Couture P, Brun LD, Szots F, Lelièvre M, Gaudet D, Després JP, Simard J, Lupien PJ, Gagné C.

Arterioscler Thromb Vasc Biol. 1998 Jun;18(6):1007-12.

PMID:
9633944
8.

Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.

Couillard C, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ, Després JP.

Diabetes Care. 1998 May;21(5):782-6.

PMID:
9589240
9.

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.

Cantin B, Gagnon F, Moorjani S, Després JP, Lamarche B, Lupien PJ, Dagenais GR.

J Am Coll Cardiol. 1998 Mar 1;31(3):519-25.

10.

Identification of three mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians.

Couture P, Vohl MC, Gagné C, Gaudet D, Torres AL, Lupien PJ, Després JP, Labrie F, Simard J, Moorjani S.

Hum Mutat. 1998;Suppl 1:S226-31. No abstract available.

PMID:
9452094
11.

Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian population.

Julien P, Gagné C, Murthy MR, Lévesque G, Moorjani S, Cadelis F, Hayden MR, Lupien PJ.

Hum Mutat. 1998;Suppl 1:S148-53. No abstract available.

PMID:
9452071
12.

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

Ooi TC, Heinonen T, Alaupovic P, Davignon J, Leiter L, Lupien PJ, Sniderman AD, Tan MH, Tremblay G, Sorisky A, Shurzinske L, Black DM.

Arterioscler Thromb Vasc Biol. 1997 Sep;17(9):1793-9.

PMID:
9327779
13.

Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program treatment goals.

Davidson MH, Nawrocki JW, Weiss SR, Schwartz SL, Lupien PJ, Jones PH, Haber HE, Black DM.

Am J Cardiol. 1997 Aug 1;80(3):347-8.

PMID:
9264433
14.

Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of Quebec.

Vohl MC, Moorjani S, Roy M, Gaudet D, Torres AL, Minnich A, Gagné C, Tremblay G, Lambert M, Bergeron J, Couture P, Perron P, Blaichman S, Brun LD, Davignon J, Lupien PJ, Després JP.

Clin Genet. 1997 Jul;52(1):1-6.

PMID:
9272705
15.

Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Lamarche B, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP.

Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1098-105.

PMID:
9194760
16.

Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia.

Vohl MC, Gaudet D, Moorjani S, Tremblay G, Perron P, Gagné C, Lesiège D, Bergeron J, Lupien PJ, Després JP.

Eur J Clin Invest. 1997 May;27(5):366-73.

PMID:
9179542
17.

The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity.

Vohl MC, Lamarche B, Bergeron J, Moorjani S, Prud'homme D, Nadeau A, Tremblay A, Lupien PJ, Bouchard C, Després JP.

Atherosclerosis. 1997 Feb 10;128(2):183-90.

PMID:
9050775
18.

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP.

Circulation. 1997 Jan 7;95(1):69-75.

PMID:
8994419
19.

Associations between 12 year changes in body fatness and lipoprotein-lipid levels in men and women of the Québec Family Study.

Couillard C, Lemieux S, Moorjani S, Lupien PJ, Thériault G, Prud'homme D, Tremblay A, Bouchard C, Després JP.

Int J Obes Relat Metab Disord. 1996 Dec;20(12):1081-8.

PMID:
8968853
20.

Importance of outside hospital mortality as a first acute ischemic heart event: the Quebec Cardiovascular Study.

Dagenais GR, Cantin B, Dagenais F, Lupien PJ, Robitaille NM, Bogaty P.

Can J Cardiol. 1996 Oct;12(10):914-8.

PMID:
9191480
21.

Risk factors for ischaemic heart disease: is it time to measure insulin?

Després JP, Lamarche B, Mauriège P, Cantin B, Lupien PJ, Dagenais GR.

Eur Heart J. 1996 Oct;17(10):1453-4. No abstract available.

PMID:
8909893
22.

The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men.

Vohl MC, Tchernof A, Dionne FT, Moorjani S, Prud'homme D, Bouchard C, Nadeau A, Lupien PJ, Després JP.

Diabetes. 1996 Oct;45(10):1405-11.

PMID:
8826978
23.

Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.

Torres AL, Moorjani S, Vohl MC, Gagné C, Lamarche B, Brun LD, Lupien PJ, Després JP.

Atherosclerosis. 1996 Sep 27;126(1):163-71.

PMID:
8879444
24.

Overfeeding in identical twins: 5-year postoverfeeding results.

Bouchard C, Tremblay A, Després JP, Nadeau A, Lupien PJ, Moorjani S, Thériault G, Kim SY.

Metabolism. 1996 Aug;45(8):1042-50.

PMID:
8769366
25.

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.

Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Després JP.

Circulation. 1996 Aug 1;94(3):273-8.

PMID:
8759066
26.

Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity-insulin resistance dyslipidemic syndrome.

Couillard C, Lamarche B, Tchernof A, Prud'homme D, Tremblay A, Bouchard C, Moorjani S, Nadeau A, Lupien PJ, Després JP.

Metabolism. 1996 Jul;45(7):882-8.

PMID:
8692026
27.

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

Tchernof A, Lamarche B, Prud'Homme D, Nadeau A, Moorjani S, Labrie F, Lupien PJ, Després JP.

Diabetes Care. 1996 Jun;19(6):629-37.

PMID:
8725863
28.

Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.

Lambert M, Lupien PJ, Gagné C, Lévy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J.

Pediatrics. 1996 May;97(5):619-28.

PMID:
8628597
29.

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ.

N Engl J Med. 1996 Apr 11;334(15):952-7.

31.

Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study.

Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ.

Atherosclerosis. 1996 Jan 26;119(2):235-45.

PMID:
8808500
32.

A monoclonal antibody against human lipoprotein lipase inhibiting heparin binding without affecting catalytic activity.

Cadelis F, Julien P, Valet JP, Deshaies Y, Ven Murthy MR, Lupien PJ.

Biochem Cell Biol. 1996;74(3):383-9.

PMID:
8883844
33.

Do elevated levels of abdominal visceral adipose tissue contribute to age-related differences in plasma lipoprotein concentrations in men?

Lemieux S, Prud'homme D, Moorjani S, Tremblay A, Bouchard C, Lupien PJ, Després JP.

Atherosclerosis. 1995 Nov;118(1):155-64.

PMID:
8579625
34.

A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia.

Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ 3rd, Stein EA, Lupien PJ, Brewer HB Jr, Raper SE, et al.

Nat Med. 1995 Nov;1(11):1148-54.

PMID:
7584986
35.

Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia.

Pimstone SN, Gagné SE, Gagné C, Lupien PJ, Gaudet D, Williams RR, Kotze M, Reymer PW, Defesche JC, Kastelein JJ, et al.

Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1704-12.

PMID:
7583547
36.

[Cardiovascular study in Quebec: importance of apolipoprotein B and insulinemia in the risk evaluation for myocardial ischemia].

Lamarche B, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP.

Union Med Can. 1995 Sep;124(2):17-21. French. No abstract available.

PMID:
8846253
37.
38.

Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study)

Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ.

Am J Cardiol. 1995 Jun 15;75(17):1189-95.

PMID:
7778537
39.

Hemolysis in primary lipoprotein lipase deficiency.

Cantin B, Boudriau S, Bertrand M, Brun LD, Gagné C, Rogers PA, Ven Murthy MR, Lupien PJ, Julien P.

Metabolism. 1995 May;44(5):652-8.

PMID:
7752915
40.

The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity.

Vohl MC, Lamarche B, Moorjani S, Prud'homme D, Nadeau A, Bouchard C, Lupien PJ, Després JP.

Arterioscler Thromb Vasc Biol. 1995 May;15(5):714-20.

PMID:
7749885
41.

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.

Nawrocki JW, Weiss SR, Davidson MH, Sprecher DL, Schwartz SL, Lupien PJ, Jones PH, Haber HE, Black DM.

Arterioscler Thromb Vasc Biol. 1995 May;15(5):678-82.

PMID:
7749881
42.

The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.

Després JP, Lemieux S, Lamarche B, Prud'homme D, Moorjani S, Brun LD, Gagné C, Lupien PJ.

Int J Obes Relat Metab Disord. 1995 May;19 Suppl 1:S76-86. Review. No abstract available.

PMID:
7550542
43.

Reduced testosterone and adrenal C19 steroid levels in obese men.

Tchernof A, Després JP, Bélanger A, Dupont A, Prud'homme D, Moorjani S, Lupien PJ, Labrie F.

Metabolism. 1995 Apr;44(4):513-9.

PMID:
7723675
44.

Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women?

St-Amand J, Després JP, Lemieux S, Lamarche B, Moorjani S, Prud'homme D, Bouchard C, Lupien PJ.

Metabolism. 1995 Apr;44(4):491-8.

PMID:
7723672
45.

Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue.

Tchernof A, Després JP, Dupont A, Bélanger A, Nadeau A, Prud'homme D, Moorjani S, Lupien PJ, Labrie F.

Diabetes Care. 1995 Mar;18(3):292-9.

PMID:
7555470
46.

Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in French Canadians.

Vohl MC, Couture P, Moorjani S, Torres AL, Gagné C, Després JP, Lupien PJ, Labrie F, Simard J.

Hum Mutat. 1995;6(3):243-6.

PMID:
8535443
47.

The response to exercise with constant energy intake in identical twins.

Bouchard C, Tremblay A, Després JP, Thériault G, Nadeau A, Lupien PJ, Moorjani S, Prudhomme D, Fournier G.

Obes Res. 1994 Sep;2(5):400-10.

48.

Detection of a novel mutation (stop 468) in exon 10 of the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians.

Simard J, Moorjani S, Vohl MC, Couture P, Torres AL, Gagné C, Després JP, Labrie F, Lupien PJ.

Hum Mol Genet. 1994 Sep;3(9):1689-91. No abstract available.

PMID:
7833932
49.

Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?

Lemieux S, Després JP, Moorjani S, Nadeau A, Thériault G, Prud'homme D, Tremblay A, Bouchard C, Lupien PJ.

Diabetologia. 1994 Aug;37(8):757-64.

PMID:
7988777
50.

Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia.

Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien PJ, Wilson JM.

Nat Genet. 1994 Apr;6(4):335-41.

PMID:
8054972

Supplemental Content

Loading ...
Support Center